Literature DB >> 1562701

The natural history of lung cancer estimated from the results of a randomized trial of screening.

S D Walter1, A Kubik, D M Parkin, J Reissigova, M Adamec, M Khlat.   

Abstract

The results from a randomized controlled trial of screening for lung cancer in Czechoslovakia have been used to estimate parameters of the natural history, using a model to simulate the disease process and the effects of screening. The results suggest that the period before clinical presentation during which lesions can be detected by screening is very short (seven to eight months). This implies that to detect three-quarters of all lung cancers by screening, two examinations per year are necessary, and that such a program would advance diagnosis by six months if there were complete participation. The results of the trial itself suggest that the benefit, in terms of a reduction in mortality from lung cancer, is likely to be very small.

Entities:  

Mesh:

Year:  1992        PMID: 1562701     DOI: 10.1007/bf00051651

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  18 in total

1.  Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer.

Authors:  O AUERBACH; A P STOUT; E C HAMMOND; L GARFINKEL
Journal:  N Engl J Med       Date:  1961-08-10       Impact factor: 91.245

2.  Lung cancer detection. Results of a randomized prospective study in Czechoslovakia.

Authors:  A Kubík; J Polák
Journal:  Cancer       Date:  1986-06-15       Impact factor: 6.860

3.  The natural history of lung cancer: a review based on rates of tumour growth.

Authors:  D M Geddes
Journal:  Br J Dis Chest       Date:  1979-01

4.  Development of carcinoma of the lung as reflected in exfoliated cells.

Authors:  G Saccomanno; V E Archer; O Auerbach; R P Saunders; L M Brennan
Journal:  Cancer       Date:  1974-01       Impact factor: 6.860

5.  The value of lung cancer detection by six-monthly chest radiographs.

Authors:  G Z Brett
Journal:  Thorax       Date:  1968-07       Impact factor: 9.139

6.  Peripheral measurable bronchogenic carcinoma. Growth rate and period of risk after therapy.

Authors:  W Weiss
Journal:  Am Rev Respir Dis       Date:  1971-02

7.  The natural history of lung cancer in a periodically screened population.

Authors:  B J Flehinger; M Kimmel
Journal:  Biometrics       Date:  1987-03       Impact factor: 2.571

8.  Estimation of the duration of a pre-clinical disease state using screening data.

Authors:  S D Walter; N E Day
Journal:  Am J Epidemiol       Date:  1983-12       Impact factor: 4.897

9.  Simplified models of screening for chronic disease: estimation procedures from mass screening programmes.

Authors:  N E Day; S D Walter
Journal:  Biometrics       Date:  1984-03       Impact factor: 2.571

10.  Pathogenesis of bronchial carcinoma, with special reference to morphogenesis and the influence on the bronchial mucosa of 20-methylcholanthrene and cigarette smoking.

Authors:  M Nasiell; E Carlens; G Auer; Y Hayata; H Kato; C Konaka; V Roger; K Nasiell; I Enstad
Journal:  Recent Results Cancer Res       Date:  1982
View more
  1 in total

Review 1.  Screening for lung cancer.

Authors:  Renée Manser; Anne Lethaby; Louis B Irving; Christine Stone; Graham Byrnes; Michael J Abramson; Don Campbell
Journal:  Cochrane Database Syst Rev       Date:  2013-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.